Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7582744 Chemically modified oligonucleotides

Patent 7582744 was granted and assigned to Alnylam Pharmaceuticals on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Alnylam Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75827440

Patent Inventor Names

Muthiah Manoharan0

Venkitasamy Kesavan0

Kallanthottathil G. Rajeev0

Date of Patent

September 1, 2009

Patent Application Number

112007030

Date Filed

August 10, 2005

Patent Citations Received

‌

US Patent 12116573 Targeting ligands for therapeutic compounds

‌

US Patent 11753643 Gene vector

‌

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

‌

US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject

‌

US Patent 12071620 Polynucleotides containing a morpholino linker

Patent Primary Examiner

‌

Tracy Vivlemore

Patent abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7582744 Chemically modified oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API